SHPH Q3 2024 Earnings — Shuttle Pharmaceuticals Holdings, Inc. Revenue & Financial Results | Market Cap Arena

SHPHShuttle Pharmaceuticals Holdings, Inc.

$1M

Q3 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$3M

Net Income

-$4M

EPS (Diluted)

$-0.37

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$45,275

Balance Sheet

Total Assets

$673,568

Total Liabilities

$2M

Stockholders' Equity

-$1M

Cash & Equivalents

$156,656

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$3M	-$2M	-90.8%
Net Income	-$4M	-$2M	-111.1%